Cycloheptyl CP 55,940 explained

Iupac Name:	(1R,3R,4R)-3-[4-(1,1-dimethylheptyl)-2-hydroxyphenyl]-4-(3-hydroxypropyl)cycloheptan-1-ol
Width:	220px
C:	25
H:	42
O:	3
Smiles:	O[C@H]1C[C@H]([C@H](CCCO)CCC1)c1ccc(cc1O)C(C)(C)CCCCCC

Cycloheptyl CP 55,940 is a synthetic cannabinoid related to CP 55,940 but is a ring-expanded homologue with a cycloheptyl ring in place of the cyclohexyl ring. It was first synthesized by Pfizer in the 1980s. It falls outside the definition of a "cyclohexylphenol derivative" since it does not have a cyclohexyl ring. Cycloheptyl CP 55,940 has similar potency to CP 55,940 itself, with an ED₅₀ of 0.06 mg/kg in animal studies.^[1]

See also

• Abeo-HHC acetate
• CP 47,497
• O-1656

Notes and References

1. 2-Hydroxy-4-(substituted) phenyl cycloalkanes and derivatives. . Johnson MR, Melvin LS . US . 4371720 . 1 February 1983 . Pfizer Inc. .